HuGE Literature Finder
Records 1-7
Potential Benefits of Bevacizumab Combined With Platinum-Based Chemotherapy in Advanced Non-Small-Cell Lung Cancer Patients With EGFR Mutation.
Clinical lung cancer 2020 Jan . Tanaka Ichidai, Morise Masahiro, Miyazawa Ayako, Kodama Yuta, Tamiya Yutaro, Gen Soei, Matsui Akira, Hase Tetsunari, Hashimoto Naozumi, Sato Mitsuo, Hasegawa Yoshino |
Prognostic effect of VEGF gene variants in metastatic non-small-cell lung cancer patients.
Angiogenesis 2019 Apr . Sullivan Ivana, Riera Pau, Andrés Marta, Altés Albert, Majem Margarita, Blanco Remei, Capdevila Laia, Barba Andrés, Barnadas Agustí, Salazar Julia |
Association between EGFR/KRAS mutation and expression of VEGFA, VEGFR and VEGFR2 in lung adenocarcinoma.
Oncology letters 2018 Aug 16 (2): 2105-2112. Yuan Xiao-Han, Yang Jie, Wang Xin-Yue, Zhang Xiao-Ling, Qin Ting-Ting, Li K |
Association between genetic polymorphisms involved in the hypoxia-inducible factor pathway and lung cancer risk: A case-control study in Japan.
Asia-Pacific journal of clinical oncology 2016 Dec . Yamamoto Yuzo, Kiyohara Chikako, Ogata-Suetsugu Saiko, Hamada Naoki, Nakanishi Yoic |
Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with pemetrexed in patients with advanced solid tumors.
Investigational new drugs 2012 Nov . Infante JR, Novello S, Ma WW, Dy GK, Bendell JC, Huff A, Wang Q, Suttle AB, Allen R, Xu CF, Ottesen LH, Burris HA, Adjei AA |
Vascular endothelial growth factor A gene (VEGFA) polymorphisms and expression of VEGFA gene in lung cancer patients of Kashmir Valley (India).
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2012 Jun 33 (3): 833-9. Naik Niyaz A, Bhat Imtiyaz A, Afroze Dil, Rasool Roohi, Mir Hyder, Andrabi Syed Irtiza, Shah Sonaullah, Siddiqi Mushtaq A, Shah Zafar |
The association of 18F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients.
Journal of experimental & clinical cancer research : CR 2010 29 (1): 69. Kim Seong-Jang, Hwang Sang-Hyun, Kim In Joo, Lee Min Ki, Lee Chang Hun, Lee Sang-Yull, Lee Eun Y |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 15, 2021
- Content source: